A federal appellate court on Wednesday seemed skeptical of nearly every argument from the Biden administration as it defended the Food and Drug Administration's power to approve a widely used abortion pill.
Why it matters: The New Orleans-based U.S. 5th Circuit Court of Appeals could decide in the coming weeks to uphold a Texas federal court ruling that ordered the FDA to withdraw its authorization of mifepristone, used in medication abortion, and set a precedent that could diminish the agency's authority in regulating medical treatments.
